Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
July 27, 2018
MannKind Corporation to Hold 2018 Second Quarter Financial Results Conference Call on August 2, 2018
WESTLAKE VILLAGE, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD) will host a conference call to discuss the 2018 second quarter and year-to-date ...
July 26, 2018
MedDay Appoints Industry Leader Christian Chavy as Chief Executive Officer
PARIS, July 26, 2018 (GLOBE NEWSWIRE) -- MedDay, a pioneering pharmaceutical company focused on the treatment of nervous system disorders, today announces the appointment of ...
July 26, 2018
CytoSorbents to Report Q2 2018 Operating and Financial Results
MONMOUTH JUNCTION, N.J., July 26, 2018 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and ...
July 26, 2018
Athenex Announces That Two Phase 3 Pivotal Efficacy Studies of KX2-391 in Actinic Keratosis Achieved Their Primary Endpoints
BUFFALO, N.Y., July 26, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies ...
July 26, 2018
ADMA Biologics Receives PDUFA Date for BIVIGAM® Regulatory Submission
RAMSEY, N.J. and BOCA RATON, Fla., July 26, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical ...
July 26, 2018
Genocea to Host Second Quarter 2018 Financial Results Conference Call & Webcast on August 2, 2018 at 9:00 a.m. ET
CAMBRIDGE, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc.(GNCA), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that it will host a ...
July 26, 2018
Galmed Pharmaceuticals to Report Second Quarter 2018 Financial Results and Provide Business Update on Thursday, August 2
TEL AVIV, Israel, July 26, 2018 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (GLMD) ("Galmedˮ or the "Company"), a clinical-stage biopharmaceutical company focused on the development of ...
July 25, 2018
BrainStorm Announces Grant of a New European Patent for NurOwn®
NEW YORK and PETACH TIKVAH, Israel, July  25, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today ...
July 25, 2018
PureTech Health Collaborator Publishes in Journal Nature Regarding New Insights into Key Role of Brain Lymphatics in Alzheimer’s and Other Neurodegenerative Diseases
PureTech Health plc (PRTC.L) ("PureTech Health"), a clinical-stage biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut (BIG), today notes the publication of foundational ...
July 25, 2018
Pfenex to Host Conference Call and Webcast Reporting Second Quarter Financial Results on Wednesday, August 8
SAN DIEGO, July 25, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE AMERICAN:PFNX) a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression ...
July 25, 2018
Conatus Pharmaceuticals to Report Second Quarter 2018 Financial Results
SAN DIEGO , July 25, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (CNAT) today announced that it will report financial results for the second quarter ...
July 25, 2018
miRagen Therapeutics to Report Second Quarter 2018 Financial Results and Host Conference Call on August 7, 2018
BOULDER, Colo., July 25, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, ...
July 25, 2018
Data from BioTime’s OpRegen® Program to Be Presented at AAO 2018
BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that its abstract “PI/IIa Study of Subretinally Transplanted Human Embryonic ...
July 25, 2018
Cormedix Inc. Announces Positive Results Of Its Neutrolin(R) Phase 3 Lock-It-100 Study Based On Recommendation By Independent Data Safety Monitoring Board
BERKELEY HEIGHTS, NJ / ACCESSWIRE / July 25, 2018 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
July 25, 2018
RedHill Biopharma Initiates Co-Promotion of HIV/AIDS Anti-Diarrheal Drug Mytesi®
TEL-AVIV, Israel and RALEIGH, N.C., July 25, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical ...
July 25, 2018
Albireo Appoints Patrick Horn MD, PhD as Chief Medical Officer
BOSTON, July 25, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
July 25, 2018
Theravance Biopharma to Report Second Quarter 2018 Financial Results on August 1
DUBLIN, July 25, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial results for the ...
July 25, 2018
PolarityTE, Inc. Provides Commercial Update
SALT LAKE CITY, July 25, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL), a commercial-stage biotechnology and regenerative biomaterials company, today announced an update on the ...
July 24, 2018
Celyad Announces FDA Acceptance of IND Application for CYAD-101, a First-in-Class Non-Gene Edited Allogeneic CAR-T Candidate
MONT-SAINT-GUIBERT, Belgium, July 24, 2018 (GLOBE NEWSWIRE) --  Celyad (Euronext Brussels:CYAD) (Euronext Paris:CYAD) (CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell therapies, ...
July 24, 2018
Sensorion Initiates Safety Study of Seliforant Versus Meclizine In Evoked Vestibular Imbalance
MONTPELLIER, France, July 24, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, today announced ...
Page 25 of 117